Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and imiquimod

fingolimod hydrochloride has been researched along with imiquimod in 4 studies

Compound Research Comparison

Studies
(fingolimod hydrochloride)		Trials
(fingolimod hydrochloride)		Recent Studies (post-2010)
(fingolimod hydrochloride)		Studies
(imiquimod)		Trials
(imiquimod)		Recent Studies (post-2010) (imiquimod)
2,7711572,0623,2642841,963

Protein Interaction Comparison

ProteinTaxonomyfingolimod hydrochloride (IC50)imiquimod (IC50)
Histamine H2 receptorHomo sapiens (human)1.506
Alpha-1D adrenergic receptorHomo sapiens (human)2.621
Adenosine receptor A2aHomo sapiens (human)5.32
7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)0.646

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Bäumer, W; Dickhaut, J; Japtok, L; Kietzmann, M; Kleuser, B; Mischke, R; Schaper, K1
Dietert, JB; Hurst, EA; Singla, P1
Corbett, A; Kermode, AG; Reddel, SW; Triplett, J1
Asano, Y; Kamata, M; Mitsui, A; Okura, I; Sato, S; Shimizu, T; Tada, Y1

Other Studies

4 other study(ies) available for fingolimod hydrochloride and imiquimod

ArticleYear
Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.
    Journal of dermatological science, 2013, Volume: 71, Issue:1

    Topics: Administration, Cutaneous; Aminoquinolines; Animals; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Cell Differentiation; Cell Proliferation; Dermatologic Agents; Disease Models, Animal; Female; Fingolimod Hydrochloride; Humans; Imiquimod; Keratinocytes; Local Lymph Node Assay; Lysophospholipids; Mice; Mice, Inbred BALB C; Mice, SCID; Propylene Glycols; Psoriasis; Receptors, Lysosphingolipid; Skin; Skin Transplantation; Sphingosine; Sphingosine-1-Phosphate Receptors; Time Factors

2013
Cells to Surgery Quiz: January 2018.
    The Journal of investigative dermatology, 2018, Volume: 138, Issue:1

    Topics: Administration, Cutaneous; Arm; Arm Injuries; Bleomycin; Botulinum Toxins, Type A; Cicatrix, Hypertrophic; Dermatologic Agents; Fingolimod Hydrochloride; Fluorouracil; Humans; Imiquimod; Signal Transduction; Skin

2018
Warts and all: Fingolimod and unusual HPV-associated lesions.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2019, Volume: 25, Issue:11

    Topics: Ankle; Antineoplastic Agents; Anus Neoplasms; Carcinoma, Squamous Cell; Cryotherapy; Fingers; Fingolimod Hydrochloride; Foot Dermatoses; Hand Dermatoses; Humans; Imiquimod; Immunosuppressive Agents; Lymphopenia; Multiple Sclerosis, Relapsing-Remitting; Papillomavirus Infections; Warts

2019
Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing ?d T cells in secondary lymph nodes.
    Journal of dermatological science, 2021, Volume: 102, Issue:2

    Topics: Animals; Disease Models, Animal; Down-Regulation; Drug Evaluation, Preclinical; Female; Fingolimod Hydrochloride; Humans; Imiquimod; Interleukin-17; Intraepithelial Lymphocytes; Langerhans Cells; Lymph Nodes; Mice; Psoriasis; Skin; Up-Regulation

2021